CGAS and neoplasm: DNA damage acquired by precancerous cells during tumorigenesis and exposure to classical cancer treatments (radiotherapy or chemotherapy) induces DNA damage and micronucleus formation, thereby activating the cGAS-STING pathway and inducing the production of type I IFNs and other cytokines that enhance anti-tumor immunity (12, 13).